These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9331798)

  • 1. Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodies.
    Zabriskie JB; Poon-King T; Blake MS; Michon F; Yoshinaga M
    Adv Exp Med Biol; 1997; 418():917-9. PubMed ID: 9331798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection.
    Sabharwal H; Michon F; Nelson D; Dong W; Fuchs K; Manjarrez RC; Sarkar A; Uitz C; Viteri-Jackson A; Suarez RS; Blake M; Zabriskie JB
    J Infect Dis; 2006 Jan; 193(1):129-35. PubMed ID: 16323141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic immunization with streptococcal immunoglobulin-binding protein Sib 35 induces protective immunity against group: a Streptococcus challenge in mice.
    Okamoto S; Tamura Y; Terao Y; Hamada S; Kawabata S
    Vaccine; 2005 Sep; 23(40):4852-9. PubMed ID: 15990202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.
    Vohra H; Dey N; Gupta S; Sharma AK; Kumar R; McMillan D; Good MF
    Res Microbiol; 2005 May; 156(4):575-82. PubMed ID: 15862457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on variation in Lancefield group A type 50 streptococcal cell-wall carbohydrate.
    Kurl DN
    Adv Exp Med Biol; 1997; 418():607-10. PubMed ID: 9331725
    [No Abstract]   [Full Text] [Related]  

  • 6. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A.
    Bessen D; Fischetti VA
    J Exp Med; 1988 Jun; 167(6):1945-50. PubMed ID: 3290383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein.
    Hasty DL; Beachey EH; Simpson WA; Dale JB
    J Exp Med; 1982 Apr; 155(4):1010-8. PubMed ID: 6174666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recombinant fragments of conservative proteins of group B streptococci as a basis of specific vaccine].
    Suvorov AN; Grabovskaia KB; Leont'eva GF; Meringova LF; Koroleva IN; Duplik NV; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):44-50. PubMed ID: 20465000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.
    Courtney HS; Hasty DL; Dale JB
    Infect Immun; 2003 Sep; 71(9):5097-103. PubMed ID: 12933852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococci.
    Liu M; Zhu H; Zhang J; Lei B
    Infect Immun; 2007 Jul; 75(7):3651-7. PubMed ID: 17502395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.
    Ahmed EA; Penfound TA; Brewer SC; Tennant PA; Chiang EY; Dale JB
    Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):51-7. PubMed ID: 19865839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
    J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface.
    Dinkla K; Sastalla I; Godehardt AW; Janze N; Chhatwal GS; Rohde M; Medina E
    Microbes Infect; 2007 Jul; 9(8):922-31. PubMed ID: 17544803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse-protective effect of rabbit anti-R-protein antibodies against group B streptococci type II carrying R-protein. Lack of effect on type III carrying R-protein.
    Lindén V
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):145-51. PubMed ID: 6346797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal opsonic mouse antibodies specific for streptococcal IgG Fc-receptor.
    Svensson M; Christensen P; Schalén D
    J Med Microbiol; 1986 Nov; 22(3):251-6. PubMed ID: 2945929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between bioluminescence and bacterial burden in passively protected mice challenged with a recombinant bioluminescent M49 group A streptococcus Strain.
    Sheel M; Pandey M; Good MF; Batzloff MR
    Clin Vaccine Immunol; 2010 Jan; 17(1):127-33. PubMed ID: 19889937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes.
    De Amicis KM; Freschi de Barros S; Alencar RE; Postól E; Martins Cde O; Arcuri HA; Goulart C; Kalil J; Guilherme L
    Vaccine; 2014 Jul; 32(32):4104-10. PubMed ID: 23994376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibodies in human sera to streptococcal groups A and C carbohydrates by a radioimmunoassay.
    Aasted B; Bernstein D; Klapper DG; El Kholy A; Krause RM
    Scand J Immunol; 1979; 9(1):61-7. PubMed ID: 368961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants.
    O'Connor SP; Cleary PP
    J Infect Dis; 1987 Sep; 156(3):495-504. PubMed ID: 3039012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization with serum opacity factor (SOF) of Streptococcus pyogenes fails to protect mice against lethal mucosal challenge with a heterologous strain.
    Schulze K; Medina E; Guzmán CA
    Vaccine; 2006 Feb; 24(9):1446-50. PubMed ID: 16289766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.